RETRACTION: Cryptotanshinone Reverses Cisplatin Resistance of Human Lung Carcinoma A549 Cells through Down-Regulating Nrf2 Pathway

被引：0
|
作者：
Xia, Chen
Bai, Xupeng
Hou, Xiangyu
Gou, Xiaoli
Wang, Yongtao
Zeng, Hang
Huang, Min
Jin, Jing
机构：
来源：
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY | 2025年 / 59卷 / 01期
关键词：
D O I：
10.33594/000000764
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [1] Cryptotanshinone Reverses Cisplatin Resistance of Human Lung Carcinoma A549 Cells through Down-Regulating Nrf2 Pathway
    Xia, Chen
    Bai, Xupeng
    Hou, Xiangyu
    Gou, Xiaoli
    Wang, Yongtao
    Zeng, Hang
    Huang, Min
    Jin, Jing
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 37 (02) : 816 - 824
  • [2] Jie Geng Tang reverses cisplatin resistance through the Nrf2 pathway in lung cancer
    Zhao, Jing
    Hou, Manting
    Ding, Kaixin
    Li, Shixiong
    Li, Hui
    Zhang, Xili
    Bai, Zhaofang
    Liu, Wenlong
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2023, 75 (06) : 784 - 805
  • [3] Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs
    Tang, Xiuwen
    Wang, Hongyan
    Fan, Longfang
    Wu, Xiaoyuan
    Xin, Ai
    Ren, Huanyu
    Wang, Xiu Jun
    FREE RADICAL BIOLOGY AND MEDICINE, 2011, 50 (11) : 1599 - 1609
  • [4] Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer
    Xie, Ying
    Feng, Sen-ling
    He, Fang
    Yan, Pei-Yu
    Yao, Xiao-Jun
    Fan, Xing-Xing
    Leung, Elaine Lai-Han
    Zhou, Hua
    PHARMACOLOGICAL RESEARCH, 2022, 186
  • [5] Metformin reverses the resistance mechanism of lung adenocarcinoma cells that knocks down the Nrf2 gene
    Zhang, Jiacui
    Jiao, Keping
    Liu, Jing
    Xia, Yu
    ONCOLOGY LETTERS, 2018, 16 (05) : 6071 - 6080
  • [6] Drug Resistance Associates With Activation of Nrf2 in MCF-7/DOX Cells, and Wogonin Reverses it by Down-Regulating Nrf2-Mediated Cellular Defense Response
    Zhong, Yan
    Zhang, Fengyi
    Sun, Zhongying
    Zhou, Wei
    Li, Zhi-Yu
    You, Qi-Dong
    Guo, Qing-Long
    Hu, Rong
    MOLECULAR CARCINOGENESIS, 2013, 52 (10) : 824 - 834
  • [7] Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT
    Yu, Meiling
    Zhang, Cuiling
    Li, Li
    Dong, Shuying
    Zhang, Naiju
    Tong, Xuhui
    ONCOLOGY REPORTS, 2014, 31 (06) : 2751 - 2758
  • [8] 3′,4′,5′,5,7-Pentamethoxyflavone Sensitizes Cisplatin-Resistant A549 Cells to Cisplatin by Inhibition of Nrf2 Pathway
    Hou, Xiangyu
    Bai, Xupeng
    Gou, Xiaoli
    Zeng, Hang
    Xia, Chen
    Zhuang, Wei
    Chen, Xinmeng
    Zhao, Zhongxiang
    Huang, Min
    Jin, Jing
    MOLECULES AND CELLS, 2015, 38 (05) : 396 - 401
  • [9] Sorafenib reverses resistance of gastric cancer to treatment by cisplatin through down-regulating MDR1 expression
    Yi-sheng Huang
    Zhi Xue
    Hua Zhang
    Medical Oncology, 2015, 32
  • [10] Sorafenib reverses resistance of gastric cancer to treatment by cisplatin through down-regulating MDR1 expression
    Huang, Yi-sheng
    Xue, Zhi
    Zhang, Hua
    MEDICAL ONCOLOGY, 2015, 32 (02)
12345